Copyright
©The Author(s) 2019.
World J Gastroenterol. Jul 21, 2019; 25(27): 3634-3648
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3634
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3634
Table 3 Characteristics of preclinical experiments on large animals in past 10 years
ID | Year | Animal | BAL system | Outcomes | Test for PERV | |||||||||
Species | No | Sex | Weight(kg) | Inducer | Type | Cell | Mass | Bioreactor | Treatment time | Survival | Other | |||
19 | 2011 | Pig | 30 | M | 10-15 | D-galactosamine | FBBAL | Alginate-chitosan encapsulated primary porcine hepatocytes | 5 × 109 | Choanoid fluidized bed bioreactor | 6 h | Survival time: BAL 72.9 ± 4.72 h Sham BAL 54.6 ± 4.09 h Control 54.8 ± 3.98 h | Decreased: lactate; glucose | NR |
20 | 2012 | Canine | 32 | NR | 10-15 | D-galactosamine | HBAL | Co-cultured porcine hepatocytes and bone marrow mesenchymal stem cells | 1x 1010 | Multi-layer flat-plate bioreactor + anionic resin adsorption column | 3 h | 7 day survival: HBAL 7/8 BAL 5/8 NBAL 4/8 Control 3/8 | Decreased: transaminases; LDH; ammonia; bilirubin; PT Increased: ALB | Negative (7 d) |
21 | 2013 | Pig | 13 | F | 25-30 | Hepaticartery ligation | NA | Alginate-encapsulated HepG2cell-spheroids | 5 × 1010 | Fluidised-bed bioreactor | 7 h | Survival time: BAL 10.5 ± 20.7 h SBAL 8.6 ± 21.4 h | Decreased: ICP; ammonia; Increased: bilirubin; acidosis | NR |
22 | 2014 | Cynomolgus monkey | 15 | M | 6.5-7.0 | D-galactosamine | HBALSS | Human hepatic CL-1 cells grown in microgravity culture | 4 × 109 | Perfusion bioreactor | 6 h | Survival time: 128 h BAL 5/10 Control 0/5 | Decreased: bilirubin; TBA; BUN; Cr; ammonia; Fischer indices Increased: ALB | NR |
23 | 2015 | Canine | 8 | NR | 10-13 | D-galactosamine | HBAL | Co-cultured porcine hepatocytes and bone marrow mesenchymal cells | 1 × 1010 | Multi-layer flat-plate bioreactor + anionic resin adsorption column | 6 h | 1 year survival: 7/8 | Decreased: transaminases; PT; bilirubin; LDH; ammonia; Increased: ALB | Negative (1 year) |
24 | 2015 | Pig | 18 | F | 45 | D-galactosamine | SRBAL | Porcine hepatocytes spheroids | 200 g | Spheroid reservoir | 24 h | Survival 90 h (%) ST 0/6, 0% ST + Non-cell 1/6,17% ST + SRBAL 5/6, 83% | Decreased: ammonia; ICP; brain water content | NR |
25 | 2016 | Pig | 21 | M | 10-15 | D-galactosamine | FBBAL | Alginate-chitosan encapsulated porcine hepatocytes | 5 × 109 | Choanoid fluidized bed bioreactor | 6h | Survival time: FBBAL 70.4 ± 11.5 h Sham FBBAL 51.6 ± 7.9 h Control 49.3 ± 6.6 h | Decreased: PCs; LPCs; FAs; SM; Increased: CBAs | NR |
26 | 2016 | Pig | 20 | NR | 15-25 | D-galactosamine | HiHep-BAL | HiHeps | 3 × 109 | Multi-layer radial-flow bioreactor | 3h | Survival 7 d: hiHep-BAL 7/8 Empty-BAL 1/6 No-BAL 0/6 | Decreased: transaminase ammonia; bilirubin; PT | NR |
27 | 2017 | Pig | 25 | F | 30-35 | Surgical ligation of all blood flow to the liver | UCLBAL | 3-dimensional (3D) HepG2-cell spheroids | 7.3 × 1010 | Fuidised bed bioreactor | 6h | Survival time: Control-BAL 7.04 ± 1.9h, n = 15 Cell-BAL 8.21 ± 2.3 h, n = 13 | Decreased: PT; INR; ICP; ammonia | NR |
28 | 2017 | Pig | 15 | M | 45-55 | Complete hepatic inflow devascularization | NA | Ca-alginate-immobilized hepatocyte spheroids | 2 × 1010 | Packed-bed bioreactor | 12h | Median survival time: Control 21 h n = 5 BAL 28.5 h n = 5 Cell-free BAL 21 h n = 5 | Decreased: ammonia; creatinine ICP; BP Increased: urine | NR |
29 | 2018 | Rhesus monkey | 30 | M | 10-20 | α-amanitin and lipopolysaccharide | SRBAL | Pig hepatocyte-HUVEC organoids | 2.6 × 1010 | Spheroid reservoir | 6 h | Median survival time: SRBAL 12 h 336 h n = 6 SRBAL 24 h 248 h n = 6 SRBAL 36 h 132 h n = 6 Sham no-cell SRBAL 12 h 90 h n = 6 Control 60.5 h n = 6 | Decreased: ammonia; bilirubin Increased: albumin | Negative (6 h) |
30 | 2019 | Pig | 18 | F | 20-30 | 85% hepatectomy | SRBAL | Porcine hepatocyte spheroids | 200g | Spheroid reservoir | 24 h | Survival rate at 90 h: SMT 0/6 SMT plus no-cell SRBAL 0/6 SMT plus SRBAL (200 g) 5/6 | Decreased: ammonia; ICP; INR Increased: volume regeneration | NR |
- Citation: He YT, Qi YN, Zhang BQ, Li JB, Bao J. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature. World J Gastroenterol 2019; 25(27): 3634-3648
- URL: https://www.wjgnet.com/1007-9327/full/v25/i27/3634.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i27.3634